article · Clinica Chimica Acta

Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

Amr Ali Mohamed Abdelgawwad El‐Sehrawy
Ghaleb Oriquat
Gulnora Shakhmurova
Divya Singhal
Bnyn Jasb Jbl
Sokhib Saidov
Uktam Ruzikulov
Shefali

2026Mansoura University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

CAR-T cell therapy research
Multiple Myeloma Research and Treatments
T-cell and B-cell Immunology

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.cca.2026.121066

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.